Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study
The 2017 retrospective observational study titled “Safety of oral alpha-lipoic acid treatment in pregnant women,” published in the European Review for Medical and Pharmacological Sciences, investigated the safety of administering 600 mg of alpha-lipoic acid daily to 610 pregnant women for at least 7 weeks during gestation. The study found
June 26, 2025
No Comments